API- Artesunate

Packaging- Single-Use Vial

Strength- 60 mg

Get an Enquiry


ARTESUNATE is an artemisinin derivative prescribed for the treatment of malaria. As an intravenous form, it is preferred to quinine for the severe malaria. Often it is prescribed as part of combination therapy together with mefloquine. The artesunate uses are not recommended for the prevention of malaria.

Dosage and Side Effects

Artesunate Injection can be administered by intravenous injection or by intramuscular by a healthcare professional. Kindly do not self administer. It is prescribed in cases where an oral administration is not appropriate.
In case you miss artesunate injection dosage, please consult your healthcare practitioner.

Most common adverse reactions include body ache, headache, bradycardia, abdominal pain, nausea, dizziness, vomiting, and diarrhoea.

Warning and Precautions

  • Care should be implemented in those patients who are with the hepatic impairment due to the potential hepatotoxic effects.
  • Patients should be monitored for 4 weeks following treatment with the inj falcigo for the evidence of hemolytic anemia.
  • In order to delay the treatment of severe malaria during pregnancy may be responsible for serious morbidity and mortality to the mother as well as fetus.
  • Patients should be advised of the need to complete the appropriate oral antimalarial therapy following treatment with artesunate 120 mg injection.
  • Patients should be instructed of the need for the regular blood tests for the 4-week period after completion of treatment in order to monitor for the post-treatment delayed hemolysis.
  • It is advised that the renal function, glucose, hepatic/haematological function is monitored throughout the treatment.
  • Patients should be monitored for signs of toxicity such as neurological symptoms, persistent vomiting/rash.
    Women with falcigo 120 mg should discuss with their healthcare provider prior to starting breastfeeding and conceiving a baby.


Is Artesunate an antimalarial drug?

Yes, Artesunate is an antimalarial drug. It is used in the treatment of severe malaria.

From which class of drug Artesunate belongs?

The artesunate 60 mg belongs to the class of drugs named artemisinin.

What are the ingredients of the medicine Artesunate?

The active ingredient in the medicine is Artesunate, and the inactive ingredients are sodium phosphate monobasic monohydrate and sodium phosphate dibasic anhydrous in water for injection.

What are commonly reported side effects of Artesunate?

The acute kidney failure requiring dialysis, yellowing of the skin as well as eyes and hemoglobin in the urine are the commonly reported artesunate side effects.

How should Artesunate be administered?

The recommended artesunate dosage should be administered intravenously at 0, 12, and 24 hours, and thereafter, administered once in a day until the patient is able to tolerate the oral antimalarial therapy.